USE OF CANAKINUMAB
- 专利权人:
- NOVARTIS AG
- 发明人:
- Paul RIDKER,Tom THUREN,Georgina BERMANN,Peter LIBBY
- 申请号：
- US16641889
- 公开号：
- US20200239564A1
- 申请日:
- 2018.08.24
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention relates to canakinumab for use in reducing the risk of or preventing recurrent cardiovascular (CV) events in a patient with elevated hsCRP that has suffered myocardial infarction (MI).
- 来源网站：
- 中国工程科技知识中心
